256 related articles for article (PubMed ID: 24803390)
1. Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.
Chen T; He S; Zhang Z; Gao W; Yu L; Tan Y
Exp Cell Res; 2014 Aug; 326(2):326-35. PubMed ID: 24803390
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.
Tan Y; Xie Z; Ding M; Wang Z; Yu Q; Meng L; Zhu H; Huang X; Yu L; Meng X; Chen Y
Stem Cells Dev; 2010 Sep; 19(9):1365-74. PubMed ID: 19916800
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
4. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
6. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide gain-of-function screen identifies novel regulators of pluripotency.
Abujarour R; Efe J; Ding S
Stem Cells; 2010 Sep; 28(9):1487-97. PubMed ID: 20629179
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of cardiac differentiation in P19 embryonal carcinoma cells regulated by Foxa2].
Zhu H; Zhang Z; Liu Y; Chen Y; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):356-64. PubMed ID: 23645235
[TBL] [Abstract][Full Text] [Related]
9. MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.
Sulaiman G; Cooke A; Ffrench B; Gasch C; Abdullai OA; O'Connor K; Elbaruni S; Blackshields G; Spillane C; Keegan H; McEneaney V; Knittel R; Rogers A; Jeffery IB; Doyle B; Bates M; d'Adhemar C; Lee MY; Campbell EL; Moynagh PN; Higgins DG; O'Toole S; O'Neill L; O'Leary JJ; Gallagher MF
Cell Death Differ; 2017 Nov; 24(11):1975-1986. PubMed ID: 28885616
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
[TBL] [Abstract][Full Text] [Related]
11. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.
Xie Z; Tan G; Ding M; Dong D; Chen T; Meng X; Huang X; Tan Y
Nucleic Acids Res; 2010 Dec; 38(22):8027-38. PubMed ID: 20702419
[TBL] [Abstract][Full Text] [Related]
12. FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.
Xue H; Liu F; Ai Z; Ke J; Yu M; Chen B; Guo Z
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668324
[TBL] [Abstract][Full Text] [Related]
13. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
14. Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.
Barrand S; Collas P
Biochem Biophys Res Commun; 2010 Jan; 391(1):762-7. PubMed ID: 19944068
[TBL] [Abstract][Full Text] [Related]
15. Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140.
Wu CY; Feng X; Wei LN
Nucleic Acids Res; 2014 Apr; 42(7):4306-17. PubMed ID: 24489122
[TBL] [Abstract][Full Text] [Related]
16. Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19 embryonal carcinoma cells via directly activating Oct4.
Li H; Fan R; Sun M; Jiang T; Gong Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):527-32. PubMed ID: 24113379
[TBL] [Abstract][Full Text] [Related]
17. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic analysis of human embryonic carcinoma cells during retinoic acid-induced neural differentiation.
Shahhoseini M; Taei A; Mehrjardi NZ; Salekdeh GH; Baharvand H
Biochem Cell Biol; 2010 Jun; 88(3):527-38. PubMed ID: 20555394
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of AdOx on gene expression in P19 embryonal carcinoma cells.
Yan L; Zhao HY; Zhang Y; Shen YF
BMC Neurosci; 2012 Jan; 13():6. PubMed ID: 22221422
[TBL] [Abstract][Full Text] [Related]
20. Jmjd3 activates Mash1 gene in RA-induced neuronal differentiation of P19 cells.
Dai JP; Lu JY; Zhang Y; Shen YF
J Cell Biochem; 2010 Aug; 110(6):1457-63. PubMed ID: 20506217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
